Brief: L&C Bio Secures World's First NMPA Approval For 'Megaderm Plus' In China
22/01/2025 12:35
Jan 22 (Reuters) - L&C Bio Co Ltd 290650.KQ :
* L&C BIO SECURES WORLD'S FIRST NMPA APPROVAL FOR 'MEGADERM
PLUS'
IN CHINA
Source text: ID:nPn3lK3gma
Further company coverage: 290650.KQ
Recent news on L&C Bio
See all newsBrief: L&C Bio Q2 Operating Profit 8.6 Billion Won, Swings To Profit From Year Earlier
Brief: L&C Bio To Acquire 10 Billion Won Worth Of Own Shares
Brief: L&C Bio Secures World's First NMPA Approval For 'Megaderm Plus' In China
Brief: L&C Bio To Acquire 5 Billion Won Worth Of Own Shares
Brief: L&C Bio Acquires Shares Worth 2 Billion Won In GeneMedicine